Retrospective studies suggest that it may be safe to extend the maintenance flushing interval of implanted ports from once every month, as recommended by the manufacturer, to once every 3 months, but ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Slow release of concentrated ranibizumab via a surgically implanted port delivery system demonstrated ...
The US Food and Drug Administration for the first time approved an implant to treat neovascular age-related macular degeneration (nAMD). By releasing a constant dose of ranibizumab, the implanted port ...
ORLANDO, Fla.--(BUSINESS WIRE)--3M Critical and Chronic Care Solutions today announces the launch of its new 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Port Dressing, designed for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results